Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)-Reference-Cited by-同舟云学术

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

Published:2012-07 Issue:6 Volume:23 Page:659-665
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Gil Miguel J.,de las Peñas Ramón,Reynés Gaspar,Balañá Carme,Peréz-Segura Pedro,García-Velasco Adelaida,Mesia Carlos,Gallego Óscar,Fernández-Chacón Concepción,Martínez-García María,Herrero Ana,Andrés Raquel,Benavides Manuel,Quintanar Teresa,Pérez-Martin Xavier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference28 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.;Stupp;N Engl J Med,2005

2. Malignant gliomas in adults.;Wen;N Engl J Med,2008

3. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.;Wick;J Clin Oncol,2010

4. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.;Wong;J Clin Oncol,1999

5. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.;Yung;Br J Cancer,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

2. Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma;Frontiers in Oncology;2022-08-03

3. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma;Journal of Neuro-Oncology;2021-10-25

4. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges;The Oncologist;2020-08-31

5. Neurotoxicity of antibodies in cancer therapy: A review;Clinical Neurology and Neurosurgery;2020-01